查詢結果分析
來源資料
相關文獻
- Case Report--Successful Treatment of Brush-evoked Pain Induced after Herpes Zoster by Trigger Point Injections with Botulinum Toxin A
- 肌筋膜痛症候群
- Intramuscular Sensory Neurolysis: A New Technique to Control Spasticity
- 以毒攻皺﹖--訪臺大醫院皮膚科臨床教授吳英俊
- The Effect of Transection of Innervating Nerve on Spontaneous Electrical Activity of Myofascial Trigger Spot in Rabbit Skeletal Muscle
- The Management for Myofascial Trigger Points
- Sequential Myofascial Trigger Point Injection to Treat a Patient with Myofascial Pain Syndrome Associated with Reflex Sympathetic Dystrophy: A Case Report
- 肌肉疼痛系列(7)--肌激痛點與針炙穴道之關係
- 肌肉疼痛系列(4)--肌激痛點之基本原理:肌激痛點之新觀點
- 肌肉疼痛系列(5)--肌激痛點之病態生理學
頁籤選單縮合
題名 | Case Report--Successful Treatment of Brush-evoked Pain Induced after Herpes Zoster by Trigger Point Injections with Botulinum Toxin A=以激痛點注射肉毒桿菌素成功治療帶狀皰疹後刷誘疼痛之病例報告 |
---|---|
作者姓名(中文) | 陳怜文; 陳貞吟; 曾劍英; 劉哲安; 馮炳勳; | 書刊名 | 疼痛醫學雜誌 |
卷期 | 21:2 2011.09[民100.09] |
頁次 | 頁77-82 |
分類號 | 416.293 |
關鍵詞 | 帶狀皰疹後神經痛; 刷誘疼痛; 激痛點; 肌筋膜痛; 肉毒桿菌素; Postherpetic neuralgia; Brush-evoked pain; Trigger points; Myofascial pain; Botulinum toxin A; |
語文 | 英文(English) |
中文摘要 | 帶狀皰疹後神經痛是帶狀皰疹後常見的併發症,它是一種慢性周邊神經性疼痛。疼痛的原因被發現不單只是神經痛,還包括肌筋膜疼痛。藥物治療是帶狀皰疹後神經痛目前主要的治療方法。但是對於那些藥物治療反應不佳或無法忍受其副作用的帶狀皰疹後神經痛的病患,必須考慮使用非藥物的治療。我們在此報告一個侵犯頸椎神經的帶狀皰疹後神經痛病例,她不僅對於藥物治療效果不佳且無法忍受藥物副作用。在這病患神經痛的區域內,我們同時發現了觸摸痛與肌膜激痛點。觸摸痛為神經痛主要特徵之一,而肌膜激痛點則是肌筋膜痛主要特點。根據肉毒桿菌素具有對神經痛及肌筋膜痛的雙重止痛機轉,我們嘗試以肉毒桿菌素注射於激痛點來治療這位病患,結果成功地治療此病患之疼痛,且止痛的效果比經皮內或皮下注射的方式更持久。就我們所知,這是第一篇以肉毒桿菌素注射於肌篩激痛點且成功地治療帶狀皰疹後刷誘疼痛的病例報告。 |
英文摘要 | Postherpetic neuralgia (PHN) is a common peripheral neuropathic pain syndrome. 4Current treatments for neuropathic pain include pharmacological and non-pharmacological management. Non-pharmacological treatments which are not the mainstay therapeutic options should be considered to manage subtypes of patients whoare refractory to medications or intolerant of the side effects of drugs. Herein, we report a 58 year-old female patient suffered from persistence of pain symptoms involving the right forth to seventh cervical roots for 4 months. The pain didn't respond well to lowdose medications. She was intolerant of the side effects of high-dose drugs. Physical examinations revealed both brush-evoked pain and myofascial trigger points on her neck, shoulder and upper arm. The pain manifestations of her PHN were comprised of sensory neuralgia and myofascial pain. Analgesic properties of Botulinum toxin A(BTX-A) have demonstrated to be beneficial in myorelaxation and have multiple effects on the sensory nervous system. Therefore, we used trigger point blocks with BTX-A once to relieve her pain successfully without recurrence of pain during the one year follow up. To our knowledge, this is the first case of brush-evoked pain induced after herpes zoster combined with myofascial pain successfully treated by trigger point injections with BTX-A. Furthermore, the duration of pain-free time compared to intradermal or subcutaneous injections was substantially greater. However,further large-scale studies are needed to replicate this clinical observation. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。